Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126892971 | 12689297 | 1 | I | 20160818 | 20160826 | 20160826 | EXP | US-SA-2016SA154217 | AVENTIS | 65.00 | YR | E | F | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126892971 | 12689297 | 1 | PS | FABRAZYME | AGALSIDASE BETA | 1 | Intravenous drip | C5782Y01 | 103979 | POWDER FOR SOLUTION FOR INFUSION | QOW | ||||||||
126892971 | 12689297 | 2 | SS | FABRAZYME | AGALSIDASE BETA | 1 | Intravenous drip | E5026Y01 | 103979 | POWDER FOR SOLUTION FOR INFUSION | QOW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126892971 | 12689297 | 1 | Fabry's disease |
126892971 | 12689297 | 2 | Fabry's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126892971 | 12689297 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126892971 | 12689297 | Cardiac disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |